PSEN1 and neoplasm: Incubation with PS1 siRNA-treated CAF-conditioned medium resulted in a significant increase in CD40 and CD86 levels in dendritic cells (p < 0.05), indicating an increase in their ability to present tumor antigens to other effector cell types (Figure 3A).